Alexion

Alexion

Alexion is focused on developing & delivering life-changing medicines for people living with rare diseases.

Keeping rare disease patients at the heart of the EU’s review of the pharmaceutical legislation Partner Content
04 Dec
Keeping rare disease patients at the heart of the EU’s review of the pharmaceutical legislation
The 2023 World Orphan Drug Congress brought together over 1600 members of the rare disease community to take a look at what needs to be done to best support rare disease patients. What were the key lessons learned across the congress?
Rare diseases: Tackling unmet needs and evolving the orphan drug environment
05 Jul
Rare diseases: Tackling unmet needs and evolving the orphan drug environment
A ‘Rare Conversation’ with EURORDIS’ Yann le Cam, Alexion’s Camilla Harder Hartvig and MEP Pernille Weiss.